To identify the most important barriers and facilitators to the participation of cisgender women living with HIV in clinical trials (perceived and real) and to establish possible mechanisms leading to refusal of trial participation. Specifically, psychosocial factors and/or cultural environments that enhance or undermine HIV-positive cisgender women's participation. These can include social inclusion, confidence in research, perceived personal vulnerability, cultural, familial and professional environment. The investigators expect to propose pragmatic solutions to enhance participation of HIV-positive cisgender women in clinical trials.
Study Type
OBSERVATIONAL
Enrollment
20
qualitative study
Hôpitaux Universitaires de Genève
Geneva, Switzerland
Evaluation of barriers and facilitators to the participation of women in clinical trials (HIV) through a questionnaire
Specific questions will be asked during a face-to-face interview to identify factors favoring or barriers to the participation of women in clinical trials.
Time frame: through study completion, an average of 1 year
Evaluation of mechanisms leading to refusal of trial participation through a questionnaire
Specific questions will be asked during a face-to-face interview to understand mechanisms leading to refusal of trial participation. Specifically, psychosocial factors and/or cultural environments that enhance or undermine HIV-positive cisgender women's participation. These can include social inclusion, confidence in research, perceived personal vulnerability, cultural, familial and professional environment.
Time frame: through study completion, an average of 1 year
Offering solutions for a better inclusion of HIV-women in clinical trials - qualitative study
Analysis of questionnaires allowing recommendations to be made
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.